Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

NCT02528214 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Dupilumab
DRUG: Placebo
DRUG: Oral corticosteroid therapy (prednisone/prednisolone)
DRUG: Inhaled corticosteroid (ICS) therapy
DRUG: Albuterol/Salbutamol
DRUG: Levalbuterol/Levosalbutamol

Sponsor

Sanofi

Collaborators

[object Object]